Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Aguzzi, A; Sigurdson, C J (2004). Antiprion immunotherapy: to suppress or to stimulate? Nature Reviews. Immunology, 4(9):725-736.

Full text not available from this repository.

Abstract

Although human prion diseases are rare, they are invariably fatal, and treatments remain elusive. Hundreds of iatrogenic prion transmissions have occurred in the past two decades, and the bovine spongiform encephalopathy epidemic has raised concerns about prion transmission from cattle to humans. Research into therapeutics for prion disease is being pursued in several centres and prominently includes immunological strategies. Currently, the options that are being explored aim either to mobilize the innate and adaptive immune systems towards prion destruction or to suppress or dedifferentiate the lymphoreticular compartments that replicate prions. This article reviews the pathophysiology of prion diseases in mouse models and discusses their relevance to immunotherapeutic and immunoprophylactic antiprion strategies.

Item Type:Journal Article, refereed
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Neuropathology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:01 September 2004
Deposited On:11 Feb 2008 13:26
Last Modified:27 Nov 2013 22:43
Publisher:Nature Publishing Group
ISSN:1474-1733
Publisher DOI:10.1038/nri1437
PubMed ID:15343371
Citations:Web of Science®. Times Cited: 47
Google Scholar™

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page